ID FGD1_MOUSE Reviewed; 960 AA. AC P52734; Q921L2; DT 01-OCT-1996, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 2. DT 24-JAN-2024, entry version 179. DE RecName: Full=FYVE, RhoGEF and PH domain-containing protein 1; DE AltName: Full=Faciogenital dysplasia 1 protein homolog; DE AltName: Full=Rho/Rac guanine nucleotide exchange factor FGD1; DE Short=Rho/Rac GEF; DE AltName: Full=Zinc finger FYVE domain-containing protein 3; GN Name=Fgd1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=8535076; DOI=10.1007/bf00352375; RA Pasteris N.G., de Gouyon B., Cadle A.B., Campbell K., Herman G.E., RA Gorski J.L.; RT "Cloning and regional localization of the mouse faciogenital dysplasia RT (Fgd1) gene."; RL Mamm. Genome 6:658-661(1995). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RC STRAIN=C57BL/6J; RX PubMed=19468303; DOI=10.1371/journal.pbio.1000112; RA Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S., She X., RA Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W., Kapustin Y., RA Meric P., Maglott D., Birtle Z., Marques A.C., Graves T., Zhou S., RA Teague B., Potamousis K., Churas C., Place M., Herschleb J., Runnheim R., RA Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z., Lindblad-Toh K., RA Eichler E.E., Ponting C.P.; RT "Lineage-specific biology revealed by a finished genome assembly of the RT mouse."; RL PLoS Biol. 7:E1000112-E1000112(2009). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC STRAIN=FVB/N; TISSUE=Mammary tumor; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH DBNL AND CTTN, AND RP MUTAGENESIS OF PRO-159; PRO-162 AND LYS-164. RX PubMed=12913069; DOI=10.1093/hmg/ddg209; RA Hou P., Estrada L., Kinley A.W., Parsons J.T., Vojtek A.B., Gorski J.L.; RT "Fgd1, the Cdc42 GEF responsible for faciogenital dysplasia, directly RT interacts with cortactin and mAbp1 to modulate cell shape."; RL Hum. Mol. Genet. 12:1981-1993(2003). RN [5] RP POSSIBLE INTERACTION WITH CCPG1. RX PubMed=17000758; DOI=10.1128/mcb.00670-06; RA Kostenko E.V., Olabisi O.O., Sahay S., Rodriguez P.L., Whitehead I.P.; RT "Ccpg1, a novel scaffold protein that regulates the activity of the Rho RT guanine nucleotide exchange factor Dbs."; RL Mol. Cell. Biol. 26:8964-8975(2006). RN [6] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-710 AND SER-714, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Brain, and Heart; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). CC -!- FUNCTION: Activates CDC42, a member of the Ras-like family of Rho- and CC Rac proteins, by exchanging bound GDP for free GTP. Plays a role in CC regulating the actin cytoskeleton and cell shape. CC {ECO:0000269|PubMed:12913069}. CC -!- SUBUNIT: Interacts with DBNL/ABP1 and CTTN. Binds CDC42 (By CC similarity). May interact with CCPG1. {ECO:0000250, CC ECO:0000269|PubMed:12913069}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12913069}. Cell CC projection, lamellipodium {ECO:0000269|PubMed:12913069}. Cell CC projection, ruffle {ECO:0000269|PubMed:12913069}. Cytoplasm, CC cytoskeleton {ECO:0000269|PubMed:12913069}. Note=Associated with CC membrane ruffles and lamellipodia. CC -!- DOMAIN: The DH domain is involved in interaction with CCPG1. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; U22325; AAA96001.1; -; mRNA. DR EMBL; AL805937; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; BC011462; AAH11462.1; -; mRNA. DR CCDS; CCDS30467.1; -. DR RefSeq; NP_032027.2; NM_008001.4. DR AlphaFoldDB; P52734; -. DR SMR; P52734; -. DR BioGRID; 199637; 2. DR IntAct; P52734; 2. DR MINT; P52734; -. DR STRING; 10090.ENSMUSP00000026296; -. DR iPTMnet; P52734; -. DR PhosphoSitePlus; P52734; -. DR jPOST; P52734; -. DR MaxQB; P52734; -. DR PaxDb; 10090-ENSMUSP00000026296; -. DR ProteomicsDB; 271562; -. DR Pumba; P52734; -. DR Antibodypedia; 376; 85 antibodies from 21 providers. DR DNASU; 14163; -. DR Ensembl; ENSMUST00000026296.8; ENSMUSP00000026296.8; ENSMUSG00000025265.15. DR GeneID; 14163; -. DR KEGG; mmu:14163; -. DR UCSC; uc009uow.2; mouse. DR AGR; MGI:104566; -. DR CTD; 2245; -. DR MGI; MGI:104566; Fgd1. DR VEuPathDB; HostDB:ENSMUSG00000025265; -. DR eggNOG; KOG4424; Eukaryota. DR GeneTree; ENSGT00940000159438; -. DR InParanoid; P52734; -. DR OMA; QQRWMAV; -. DR OrthoDB; 5385125at2759; -. DR PhylomeDB; P52734; -. DR TreeFam; TF316247; -. DR Reactome; R-MMU-193648; NRAGE signals death through JNK. DR Reactome; R-MMU-416482; G alpha (12/13) signalling events. DR Reactome; R-MMU-9013148; CDC42 GTPase cycle. DR BioGRID-ORCS; 14163; 6 hits in 75 CRISPR screens. DR ChiTaRS; Fgd1; mouse. DR PRO; PR:P52734; -. DR Proteomes; UP000000589; Chromosome X. DR RNAct; P52734; Protein. DR Bgee; ENSMUSG00000025265; Expressed in rostral migratory stream and 240 other cell types or tissues. DR ExpressionAtlas; P52734; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IDA:MGI. DR GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell. DR GO; GO:0005794; C:Golgi apparatus; IDA:MGI. DR GO; GO:0030027; C:lamellipodium; IDA:MGI. DR GO; GO:0001726; C:ruffle; IDA:MGI. DR GO; GO:0005085; F:guanyl-nucleotide exchange factor activity; ISO:MGI. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0031267; F:small GTPase binding; ISO:MGI. DR GO; GO:0030036; P:actin cytoskeleton organization; ISO:MGI. DR GO; GO:0007010; P:cytoskeleton organization; IDA:MGI. DR GO; GO:0046847; P:filopodium assembly; ISO:MGI. DR GO; GO:0008360; P:regulation of cell shape; IDA:UniProtKB. DR CDD; cd15741; FYVE_FGD1_2_4; 1. DR CDD; cd01219; PH1_FGD1; 1. DR CDD; cd13236; PH2_FGD1-4; 1. DR CDD; cd00160; RhoGEF; 1. DR Gene3D; 1.20.900.10; Dbl homology (DH) domain; 1. DR Gene3D; 2.30.29.30; Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB); 2. DR Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc finger); 1. DR InterPro; IPR035899; DBL_dom_sf. DR InterPro; IPR000219; DH-domain. DR InterPro; IPR035941; FGD1-4_PH2. DR InterPro; IPR035939; FGD1_PH1. DR InterPro; IPR011993; PH-like_dom_sf. DR InterPro; IPR001849; PH_domain. DR InterPro; IPR000306; Znf_FYVE. DR InterPro; IPR017455; Znf_FYVE-rel. DR InterPro; IPR013083; Znf_RING/FYVE/PHD. DR PANTHER; PTHR12673; FACIOGENITAL DYSPLASIA PROTEIN; 1. DR PANTHER; PTHR12673:SF79; FYVE, RHOGEF AND PH DOMAIN-CONTAINING PROTEIN 1; 1. DR Pfam; PF01363; FYVE; 1. DR Pfam; PF00169; PH; 2. DR Pfam; PF00621; RhoGEF; 1. DR SMART; SM00064; FYVE; 1. DR SMART; SM00233; PH; 2. DR SMART; SM00325; RhoGEF; 1. DR SUPFAM; SSF48065; DBL homology domain (DH-domain); 1. DR SUPFAM; SSF50729; PH domain-like; 2. DR PROSITE; PS50010; DH_2; 1. DR PROSITE; PS50003; PH_DOMAIN; 2. DR PROSITE; PS50178; ZF_FYVE; 1. DR Genevisible; P52734; MM. PE 1: Evidence at protein level; KW Cell projection; Cytoplasm; Cytoskeleton; KW Guanine-nucleotide releasing factor; Metal-binding; Phosphoprotein; KW Reference proteome; Repeat; Zinc; Zinc-finger. FT CHAIN 1..960 FT /note="FYVE, RhoGEF and PH domain-containing protein 1" FT /id="PRO_0000080941" FT DOMAIN 372..560 FT /note="DH" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00062" FT DOMAIN 589..688 FT /note="PH 1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00145" FT DOMAIN 820..920 FT /note="PH 2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00145" FT ZN_FING 729..789 FT /note="FYVE-type" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT REGION 1..210 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 226..355 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 701..725 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT REGION 922..960 FT /note="Disordered" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT MOTIF 171..187 FT /note="SH3-binding" FT /evidence="ECO:0000255" FT COMPBIAS 132..190 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 229..254 FT /note="Pro residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 283..299 FT /note="Polar residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT COMPBIAS 336..351 FT /note="Acidic residues" FT /evidence="ECO:0000256|SAM:MobiDB-lite" FT BINDING 735 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT BINDING 738 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT BINDING 752 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT BINDING 755 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT BINDING 760 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT BINDING 763 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT BINDING 781 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT BINDING 784 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_label="2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00091" FT MOD_RES 48 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P98174" FT MOD_RES 205 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P98174" FT MOD_RES 710 FT /note="Phosphothreonine" FT /evidence="ECO:0007744|PubMed:21183079" FT MOD_RES 714 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:21183079" FT MUTAGEN 159 FT /note="P->A: Abolishes binding to DBNL." FT /evidence="ECO:0000269|PubMed:12913069" FT MUTAGEN 162 FT /note="P->A: Abolishes binding to DBNL." FT /evidence="ECO:0000269|PubMed:12913069" FT MUTAGEN 164 FT /note="K->E: No effect on binding to DBNL." FT /evidence="ECO:0000269|PubMed:12913069" FT CONFLICT 504 FT /note="G -> R (in Ref. 1; AAA96001)" FT /evidence="ECO:0000305" FT CONFLICT 633 FT /note="S -> T (in Ref. 1; AAA96001)" FT /evidence="ECO:0000305" SQ SEQUENCE 960 AA; 106365 MW; E3E489BA2F3AE056 CRC64; MHGHRVPGGP GPSDPERSAA NTPGAAPLAC ADSDPGALEP GLPVSRGSGT ALGGPLDPQF VGPSDASLGA PPSSRVLPCG PSPQHHRALR FSYHLEGSQP RPGLHQGNRI LVKSLSLDPG QSLEPHPEGP QRLRSDPGPP TEIPGPRPSP LKRAPGPKPQ VPPKPSYLQM PRVLPPPEPI PPPPSRPLPA DPRVAKGLVP RAEASTSSAA VSSLIEKFER EPVIVASDRP APGPCPVPPE PAMLPQPPPQ PTGSQLPEGE ASRCLFLLAP GPRDGEKVPN RDSGIDSISS PSNSEETCFV SDDGPPIHSL CPGPPALASM PVALADPHRP GSQEVDSDLE EEEEEEEEEK EREIPVPPME RQESVELTVQ QKVFHIANEL LQTEKAYVSR LHLLDQVFCA RLLEEARNRS SFPADVVHGI FSNICSIYCF HQQFLLPELE KRMEEWDRYP RIGDILQKLA PFLKMYGEYV KNFDRAVELV NTWTERSTQF KVIIHEVQKE EACGNLTLQH HMLEPVQRIP RYELLLKDYL LKLPHGSPDS KDAQKSLELI ATAAEHSNAA IRKMERMHKL LKVYELLGGE EDIVSPTKEL IKEGHILKLS AKNGTTQDRY LILFNDRLLY CVPRLRLLGQ KFSVRARIDV DGMELKESSN LNMPRTFLVS GKQRSLELQA RTEEEKKDWV QAINSTLLKH EQTLETFKLL NSTNRDDEDT PPNSPNVDLG KRAPTPIREK EVTMCMRCQE PFNSITKRRH HCKACGHVVC GKCSEFRARL IYDNNRSNRV CTDCYVALHG APGSSPACSQ HTPQRRRSIL EKQASVAAEN SVICSFLHYM EKGGKGWHKA WFVVPENEPL VLYIYGAPQD VKAQRSLPLI GFEVGPPEAG ERPDRRHVFK ITQSHLSWYF SPETEELQRR WMAVLGRAGR GDTFCPGPTL SEDKEMEETP VAASGATAEP PEASQTRDKT //